0001209191-17-016696.txt : 20170302 0001209191-17-016696.hdr.sgml : 20170302 20170302164636 ACCESSION NUMBER: 0001209191-17-016696 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170228 FILED AS OF DATE: 20170302 DATE AS OF CHANGE: 20170302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1095 AVENUE OF AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 1095 AVENUE OF AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANDARIAN STEVEN A CENTRAL INDEX KEY: 0001255728 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15787 FILM NUMBER: 17659566 MAIL ADDRESS: STREET 1: METLIFE STREET 2: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-28 0 0001099219 METLIFE INC MET 0001255728 KANDARIAN STEVEN A 200 PARK AVENUE NEW YORK NY 10166 1 1 0 0 Chairman, President & CEO Common Stock 2017-02-28 4 A 0 38628 52.44 A 279246.5844 D Common Stock 2017-02-28 4 F 0 20029 52.44 D 259217.5844 D Common Stock 120000 I By GRAT Employee Stock Option (Right to Buy) 52.44 2017-02-28 4 A 0 150172 0.00 A 2027-02-27 Common Stock 150172 150172 D Restricted Stock Units 2017-02-28 4 A 0 50058 0.00 A Common Stock 50058 50058 D Shares acquired from the payout of 2014-2016 Performance Shares following determination of the performance factor for such award. Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. The options become exercisable in three equal installments on February 28, 2018, 2019, and 2020. Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. The Restricted Stock Units vest in three equal installments on the first business day in March 2018, 2019 and 2020. Mark A. Schuman, authorized signer 2017-03-02